# Hong Kong and Taiwan HM3 PMS

> **NCT04703855** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 3 (actual)

## Conditions studied

- Advanced Heart Failure

## Interventions

- **DEVICE:** HeartMate 3™ left ventricular assist system (HM3 LVAS)

## Key facts

- **NCT ID:** NCT04703855
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-14
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Low enrollment and regulatory status change
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703855, "Hong Kong and Taiwan HM3 PMS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04703855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*